Paramedic Papers

Home Toxicology Kratom derivative withdrawal treated prehospital

Toxicology

Kratom derivative withdrawal treated prehospital

Community Paramedics Addressing the Evolving Opioid Crisis: A Case Series Addressing the Kratom Derivatives 7-Hydroxymitragynine and MGM-15
Prehospital Emergency Care · 2026-10-22 · Added 25 October 2026

A US case series describes community paramedics treating severe withdrawal from concentrated kratom derivatives (7-hydroxymitragynine and MGM-15) with full-dose buprenorphine and rapid linkage to outpatient medication for opioid use disorder, with both patients retained in treatment at 30 days.

Study type
Case series
Design
Case series, US community paramedic buprenorphine program
Participants
2 patients
Main finding
Buprenorphine 24 mg and 32 mg/8 mg with naloxone treated severe 7-OH/MGM-15 withdrawal; both patients were linked to outpatient treatment within 48 hours and retained in treatment at 30 days
Caveat
Two cases, no comparison or systematic outcome measurement
Bottom line
Context only

Why it matters in Australia (Medium relevance). Buprenorphine is not something Australian ambulances carry — adoption would need a guideline change — but concentrated 7-OH products are sold over the counter and online, and crews will meet the dependence and withdrawal they cause.

Learning goal

Recognise emerging synthetic kratom derivative toxicity and withdrawal presentations that may require buprenorphine-based management.

Open in dashboard Read the paper (DOI) PubMed

More

Related papers on Toxicology